GGrantIndex
← Leaderboards

Susan E. Bergeson

University Of Texas Austin

$8,241,097
Attributed
$13,373,014
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,373,014 · 7

By mechanism

U01$11,690,842 · 3
R21$839,863 · 2
K01$681,808 · 1
R41$160,501 · 1

Top collaborators

Most similar at University Of Texas Austin

Same institution · by research overlap

Others in their field

Top investigators on “Ethanol

Research focus

EthanolMorbidity - Disease RateDrinkingLeadAlcohol ConsumptionCollaborationsExcisionAlcoholism /Alcohol AbuseComplexWithdrawalAlcohol Abuse TherapyGene ExpressionAnimalsFda ApprovedPharmaceutical PreparationsMinocyclinePublic Health RelevanceGenetic PolymorphismHeavy DrinkingAcuteAlcohol Use DisorderClinical TreatmentHigh Risk DrinkingAlcohol Dependence

Grant awards (30)

Medication Development for the Treatment of Alcohol Use Disorder$354,877
U01 · FY2025 · AA · contact PI
Medication Development for the Treatment of Alcohol Use Disorder$1,379,570
U01 · FY2024 · AA · contact PI
Medication Development for the Treatment of Alcohol Use Disorder$1,401,264
U01 · FY2023 · AA · contact PI
Supplement to: Medication Development for the Treatment of Alcohol Use Disorder - U01AA028957$152,998
U01 · FY2023 · AA · contact PI
Medication Development for the Treatment of Alcohol Use Disorder$1,462,937
U01 · FY2022 · AA · contact PI
Medication Development for the Treatment of Alcohol Use Disorder$1,486,106
U01 · FY2021 · AA · contact PI
Medication Development for the Treatment of Alcohol Use Disorder$1,521,805
U01 · FY2020 · AA · contact PI
Chemically modified minocycline for treatment of alcohol use disorder$798,758
U01 · FY2019 · AA · contact PI
Chemically modified minocycline for treatment of alcohol use disorder$824,590
U01 · FY2018 · AA · contact PI
Development of Tetracycline Analogs for Alcohol Use Disorder Treatment$160,501
R41 · FY2018 · AA
Neuroimmune Interactions in High Alcohol Drinking$210,550
R21 · FY2014 · AA · contact PI
Neuroimmune Interactions in High Alcohol Drinking$179,313
R21 · FY2013 · AA
Molecular Basis of Excessive Alcohol Drinking$257,388
U01 · FY2010 · AA · contact PI
Molecular Basis of Excessive Alcohol Drinking$252,419
U01 · FY2009 · AA · contact PI
Molecular Basis of Excessive Alcohol Drinking$242,642
U01 · FY2008 · AA · contact PI
Molecular Basis of Excessive Alcohol Drinking$235,015
U01 · FY2007 · AA · contact PI
Molecular Basis of Excessive Alcohol Drinking$234,130
U01 · FY2006 · AA · contact PI
Genetic and alcohol regulation of brain RNA levels$141,301
K01 · FY2006 · AA · contact PI
Molecular basis of excessive alcohol drinking$212,879
U01 · FY2005 · AA
Genetic and alcohol regulation of brain RNA levels$138,758
K01 · FY2005 · AA
Molecular basis of excessive alcohol drinking$216,258
U01 · FY2004 · AA
Genetic and alcohol regulation of brain RNA levels$136,290
K01 · FY2004 · AA
Molecular basis of excessive alcohol drinking$219,398
U01 · FY2003 · AA
Microarray Analysis of Alcohol Withdrawal Syndrome$150,000
R21 · FY2003 · AA
Genetic and alcohol regulation of brain RNA levels$133,893
K01 · FY2003 · AA
Molecular basis of excessive alcohol drinking$222,308
U01 · FY2002 · AA
Microarray Analysis of Alcohol Withdrawal Syndrome$150,000
R21 · FY2002 · AA
Genetic and alcohol regulation of brain RNA levels$131,566
K01 · FY2002 · AA
Molecular basis of excessive alcohol drinking$215,500
U01 · FY2001 · AA
Microarray Analysis of Alcohol Withdrawal Syndrome$150,000
R21 · FY2001 · AA